等待开盘 03-26 09:30:00 美东时间
-0.060
-1.35%
FDA provided constructive feedback on AEON Biopharma’s analytical similarity strategy for its biosimilar candidate ABP-450, intended to match BOTOX®. The company plans to complete its analytical program in 2026 and request a BPD Type 2b meeting with the FDA to discuss the next steps in development.
03-25 12:00
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
03-21 04:05
AEON Biopharma appoints John Bencich as CFO to strengthen financial strategy and advance regulatory milestones for its lead asset, ABP-450, a biosimilar to BOTOX®. With over 25 years of experience in biotechnology and capital markets, Bencich aims to support the company's growth and position it for long-term value creation. AEON targets the U.S. therapeutic neurotoxin market, valued at over $3 billion annually, with ABP-450 already approved as a ...
03-09 20:05
获24亿美元电厂合同,BW暴涨近46%;业绩超预期!Q4营收同比增长14%,Stevanato Group涨近19%>>
03-05 14:59
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Evolus (EOLS) shares jumped ~36% on Wednesday, its biggest intraday gain in nearly half a decade, after the maker of Jeuveau anti-wrinkle therapy exceeded Street forecasts with its Q4 2025 financials,...
03-05 03:47
Moderna涨7.8%,专利纠纷靴子即将落地。罗斯百货涨6.5%,Q4销售额创新高。云计算公司CoreWeave涨5.7%,Perplexity签约使用其数据...
03-04 22:30
周三美国股指期货的抛售势头趋于停滞,因为交易员越来越有信心认为伊朗战争对油价的影响可能小于最初担心的程度。在避险推动美元连续两天上涨之后,美元涨势也暂时歇脚...
03-04 21:30
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05